SFX by Ex Libris Inc.

Title:	Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
Source:	Cell [0092-8674] Robertson, A G yr:2018

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Going, James J J. "Human breast duct anatomy, the 'sick lobe' hypothesis and intraductal approaches to breast cancer." Breast cancer research and treatment 97.3 (2006): 285-91.
description	2.	Margolese, Richard G. "Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial." The Lancet 387.10021 (2015): 849-856.
description	3.	Roldan, G. "Tumoral expression of BRCA1, estrogen receptor alpha and ID4 protein in patients with sporadic breast cancer." Cancer biology & therapy 5.5 (2006): 505-510.
description	4.	Zheng, S. "Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma." Cancer cell 29.5 (2016): 723-736.
description	5.	Tang, E. "Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo." Genes & development 29.16 (2015): 1707-20.
description	6.	Rusby, Jennifer E E. "Breast duct anatomy in the human nipple: three-dimensional patterns and clinical implications." Breast cancer research and treatment 106.2 (2008): 171-9.
description	7.	Jong, Roberta A A. "Technical developments in mammography." Health physics 95.5 (2008): 599-611.
description	8.	de Candia, P. "Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma." Human pathology 37.8 (2006): 1032-41.
description	9.	Mai, K T T. "Pattern of distribution of intraductal and infiltrating ductal carcinoma: a three-dimensional study using serial coronal giant sections of the breast." Human pathology 31.4 (2000): 464-74.
description	10.	Going, J J J. "Three dimensional anatomy of complete duct systems in human breast: pathological and developmental implications." Journal of clinical pathology 49.1 (1995): 48-52.
description	11.	Roy, D. "Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations." Cancer cell 29.5 (2016): 737-750.
description	12.	Ceccarelli, M. "Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma." Cell 164.3 (2016): 550-563.
description	13.	Ganz, Patricia A. "Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial." The Lancet 387.10021 (2015): 857-865.
description	14.	Bernhard, J. "Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials." Lancet oncology 16.7 (2015): 848-58.
description	15.	Teo, Lalarukh H. "LGR5 activates non-canonical Wnt-signaling and inhibits aldosterone production in the human adrenal." The Journal of clinical endocrinology and metabolism 100.6 (2015): 836-44.
description	16.	Allred, Stewart C. "Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor-Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24." Journal of clinical oncology 30.12 (2012): 1268-1273.
description	17.	Groen, Harry J M J. "Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non-Small-Cell Lung Cancer: The NVALT-4 Study." Journal of clinical oncology 29.32 (2011): 4320-4326.
description	18.	Nelson, D F F. "Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315." International journal of radiation oncology, biology, physics 23.1 (1992): 9-17.
description	19.	Umetani, N. "Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer." Oncogene 24.29 (2005): 4721-7.
description	20.	Slade, A. "The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death." Cancer research 66.5 (2006): 2757-64.